| abstract |
Administration to a mammal of small doses of bodies, such as liposomes, of a size similar to that of mammalian cells. These bodies have major groups of glycerol phosphate on their external surfaces, and beneficially affect the symptoms, which include biochemical correlates of multiple sclerosis (MS) in said mammal. Liposomes composed of 50-100% phosphatidylglycerol are preferred, where the main phosphoglycerol groups are located on the outer surface. |